Evidence map›Paper›PMID 41510407›Full record

ArticleCureus2025

Educational Resilience During the COVID-19 Pandemic: A Descriptive Evaluation of Medical School and Licensing Examination Policies in Japan.

Takahiro Maruyama, Yudai Kaneda, Sota Sugiura, Tetsuya Tanimoto, Akihiko Ozaki

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Takahiro MaruyamaSchool of Medicine, International University of Health and Welfare, Tokyo, JPN.
Yudai KanedaMedical Education, Clinical Training Center, Jyoban Hospital, Tokiwa Foundation, Iwaki, JPN.
Sota SugiuraSchool of Medicine, University of Tokyo, Tokyo, JPN.
Tetsuya TanimotoInternal Medicine, Navitas Clinic, Tokyo, JPN.
Akihiko OzakiSurgery/Breast Surgery, Jyoban Hospital, Tokiwa Foundation, Iwaki, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe COVID-19 pandemic significantly disrupted medical education worldwide, highlighting critical vulnerabilities in educational continuity, especially in the context of high-stakes examinations. This study investigates how medical schools and national examination authorities in Japan responded to these challenges, focusing on the provision of make-up and alternative testing measures.

methodsWe analyzed the availability of make-up and alternative examination options in 82 Japanese medical schools and across 22 national licensing examinations for medical-related professions between 2021 and 2023. Data were collected from official websites of the Ministry of Health, Labour and Welfare, the Ministry of Education, Culture, Sports, Science and Technology, and individual university admissions materials.

resultsMost universities offered make-up examinations or alternative assessment options to students impacted by COVID-19, with a slight decrease in compliance over three years (82% in 2021, 80% in 2022, 76% in 2023). However, none of the national examinations for medical-related professions implemented make-up examinations or similar measures.

conclusionJapanese medical schools demonstrated flexibility in adapting examination policies during the pandemic, in contrast to the rigid approach of national licensing examinations. This disparity raises important concerns regarding educational equity and public health preparedness and may also lead to significant financial hardship and career delays for affected examinees. These findings underscore the need for unified, crisis-responsive policies to support students during future health emergencies.

Indexed as

covid-19education equityexaminationjapanmedical students

Identifiers

PMID41510407
PMCPMC12774861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.